Research  >  About SRI  >  Scientist Profiles

Scientist profiles S-Z

SRI Profiles

Ken Shulman
Kenneth Shulman, MD, SM, FRCPsych, FRCP(C)

Affiliate scientist

Sunnybrook Health Sciences Centre
2075 Bayview Ave., Room FG 11
Toronto, ON
M4N 3M5

Phone: 416-480-4079
Fax: 416-480-6022

Administrative Assistant: Lukshmy Parameswaran

Phone: 416-480-4079
Fax: 416-480-6022


  • MD, 1973, University of Toronto, Canada
  • MRCPsych, 1978, U.K.
  • FRCP(C), 1978
  • SM, 1990, health policy and management, School of Public Health, Harvard University, U.S.

Appointments and Affiliations:

Research Foci:

  • Cognitive screening (focus on clock-drawing test)
  • Bipolar disorder in older adults
  • Pharmacoepidemiology of mood stabilizers in late life
  • Testamentary capacity

Research Summary:

Dr. Shulman is interested in developing a valid and practical brief cognitive screening battery for use in an elderly population. His focus has been on the use of the clock drawing test combined with a memory and informant screen in order to detect early signs of dementia and to monitor change in cognition.

As a member of the NET (new emerging team) group at the Institute for Clinical Evaluative Sciences, he is interested in using large health care databases to study the pharmacoepidemiology of late-life mood disorders. In particular, he is interested in the use of mood stabilizers, especially lithium carbonate, and understanding the use and adverse events associated with lithium in an older population.

Dr. Shulman has also been involved in the development of medico-legal guidelines for the assessment of testamentary capacity; for example, executing a legal will and vulnerability to undue influence.

Selected Publications:

See current publications list at PubMed.

  1. Amodeo S, Mainland B, Herrmann N, Shulman K. The times they are a-changin’: clock drawing and prediction of dementia. Journal of Geriatric Psychiatry and Neurology. 2015;28(2):145–155.
  2. Shulman K, Hull, IM, De Koven S, Amodeo S, Mainland B, Herrmann N. Cognitive fluctuations and the lucid Interval in dementia: Implications for testamentary capacity. J Am Acad Psychiatry Law. 2015; 43(3):28–92.
  3. Mainland BJ, Amodeo S, Shulman KI. Multiple clock drawing scoring systems: Simpler is better. Int J Geriatr Psychiatry. 2014;29(2):127–136.
  4. Shulman K, Herrmann N, Walker SE. Current place of monoamine oxidase inhibitors in the treatment of depression. CNS Drugs. 2013;27(10):789–97.
  5. Shulman K. Clock-drawing: Is it the ideal cognitive screening test? Int J Geriatr Psychiatry. 2000;15:548–561.

Related News and Stories: